Etelcalcetide Hydrochloride

盐酸依特卡肽

Report date: 2025/11/21 16:48:24
NME

Base Information

Drug NameEtelcalcetide Hydrochloride
Drug Alias Nameetelcalcetida维卡塞肽盐酸维拉卡肽Velcalcetide伊特卡肽 +[16] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCalcium sensing receptor agonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsHyperparathyroidism, SecondaryEdema, CardiacKidney Failure, Chronic +[4] 
Global Approved IndicationsHyperparathyroidism, Secondary
Approved Indications in ChinaHyperparathyroidism, Secondary
Original Approved Country/TerritoryEU
Original Approved Date2016/11/11
Country/TerritoryCzechiaBelgiumCanada +[37] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen Europe BvAmgen IncKai Pharmaceuticals Inc +[5] 
Inactive CompaniesN/A
Active IndicationsHyperparathyroidism, SecondaryKidney Failure, ChronicRenal Insufficiency, Chronic
Inactive IndicationsEdema, Cardiac

Other Information

ATC CodeH05BX04
Related LinksWikipediaDrugBankKEGG